{'fraction_non_alphanumeric': 0.0359375, 'fraction_numerical': 0.00625, 'mean_word_length': 5.223300970873787, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Seroepidemiologic studies in 63 patients given organ transplants in relation to cytomegalovirus, herpes simplex, varicella-zoster and HTLV-III: validity and limits].

We carried out a seroepidemiological study on 63 patients undergoing organ transplantation in order to determine viral markers like CMV, HTLV III, HS and V/Z. The antibodies valuation was carried out by enzyme-linked immunosorbent assays (ELISA-Abbott) and complement fixation test. All the tested markers give a high percentage of positivity even if the values relevant to anti-HTLV III antibodies can not be related to infection but, probably, to anti-HLA-Dr antibodies.